Oridonin ring A-based diverse constructions of enone functionality: identification of novel dienone analogues effective for highly aggressive breast cancer by inducing apoptosis
Related Experiment Video
Updated: May 6, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Chunyong Ding1, Yusong Zhang, Haijun Chen
1Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch , Galveston, Texas 77555, United States.
Abstract:
Oridonin (1) has attracted considerable attention in recent years because of its unique and safe anticancer pharmacological profile. Nevertheless, it exhibits moderate to poor effects against highly aggressive cancers including triple-negative and drug-resistant breast cancer cells. Herein, we report the rational design and synthesis of novel dienone derivatives with an additional α,β-unsaturated ketone system diversely installed in the A-ring based on this class of natural scaffold that features dense functionalities and stereochemistry-rich frameworks. Efficient and regioselective enone construction strategies have been established. Meanwhile, a unique 3,7-rearrangement reaction was identified to furnish an unprecedented dienone scaffold. Intriguingly, these new analogues have been demonstrated to significantly induce apoptosis and inhibit colony formation with superior antitumor effects against aggressive and drug-resistant breast cancer cells in vitro and in vivo while also exhibiting comparable or lower toxicity to normal human mammary epithelial cells in comparison with 1.
Insights
Novel dienone derivatives show enhanced anticancer activity against aggressive breast cancer. These compounds effectively induce apoptosis and inhibit colony formation, offering a promising alternative to Oridonin.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Organic Synthesis
Background:
- Oridonin (1) possesses anticancer properties but shows limited efficacy against aggressive and drug-resistant breast cancers.
- There is a need for novel anticancer agents with improved potency and broader applicability.
Purpose of the Study:
- To design and synthesize novel dienone derivatives based on the Oridonin scaffold.
- To evaluate the in vitro and in vivo antitumor activity of these new analogues against aggressive and drug-resistant breast cancer cells.
Main Methods:
- Rational design and synthesis of dienone derivatives featuring an α,β-unsaturated ketone system.
- Development of efficient and regioselective enone construction strategies.
- Identification of a unique 3,7-rearrangement reaction for novel scaffold generation.
Main Results:
- Successfully synthesized novel dienone analogues with diverse A-ring modifications.
- Demonstrated significant induction of apoptosis and inhibition of colony formation in aggressive breast cancer cells.
- Achieved superior antitumor effects in vitro and in vivo compared to Oridonin.
- Exhibited comparable or lower toxicity to normal human mammary epithelial cells.
Conclusions:
- The novel dienone derivatives exhibit enhanced anticancer efficacy against aggressive and drug-resistant breast cancer.
- These compounds represent a promising new class of anticancer agents with a favorable safety profile.
More Related Videos
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Related Concept Videos
Base-Catalyzed Ring-Opening of Epoxides
Nuclear Overhauser Enhancement (NOE)
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Inhibition of Cdk Activity
Acid-Catalyzed Ring-Opening of Epoxides